Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study

Rheumatoid arthritis (RA) is characterized by inflammation and an increased risk for cardiovascular disease (CVD). This study investigates possible associations between CVD and the use of conventional disease-modifying antirheumatic drugs (DMARDs) in RA. Using a case control design, 613 RA patients...

Descripción completa

Detalles Bibliográficos
Autores principales: van Halm, Vokko P, Nurmohamed, Michael T, Twisk, Jos WR, Dijkmans, Ben AC, Voskuyl, Alexandre E
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1779436/
https://www.ncbi.nlm.nih.gov/pubmed/16984661
http://dx.doi.org/10.1186/ar2045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1779436/
https://www.ncbi.nlm.nih.gov/pubmed/16984661
http://dx.doi.org/10.1186/ar2045

Ejemplares similares